ADXS +10% on licensing deal with SELLAS Life Sciences Group (a private I-O company); the deal includes $358M “biobucks,” but apparently no up-front cash:
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.